Article
MHC genotype controls the capacity of ligand density to switch T helper (Th)-1/Th-2 priming in vivo.
Journal of immunology (Baltimore, Md. : 1950) - 1 Nov 1996
Schountz T, Kasselman J P, Martinson F A, Brown L, Murray J S
Abstract excerpt
A quantitative mechanism for the differentiation of CD4 T cells into recognized subsets of Th1 and Th2 effectors is controversial. Here, we define the Ag dose more precisely to the density of a minimal immunogenic peptide presented on the surface of a specific APC type. Th1 and Th2 responder MHC genotypes differ by as much as an order of magnitude in the density of this peptide displayed on B7-2+ B cells. We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
